Albert Park: Clinical Trials

1 trial sponsored by Albert Park, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Albert Park: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
Valganciclovir, Simple Syrup - Cmv Congenital, CMV
Phase 2TerminatedAlbert Park102018-08-312026-08-27

Conditions studied

Cytomegalovirus Infections (1)  ·  Hearing Loss, Sensorineural (1)

Interventions

Valganciclovir (1)

Countries

United States (1)

Results publications

PMID 38415855

NIH funding

U01DC014706 (1)